OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Signaling Pathways of Podocyte Injury in Diabetic Kidney Disease and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors
Xiutian Chen, Jiali Wang, Yongda Lin, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3913-3913
Open Access | Times Cited: 17
Xiutian Chen, Jiali Wang, Yongda Lin, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3913-3913
Open Access | Times Cited: 17
Showing 17 citing articles:
N6-methyladenosine RNA methylation in diabetic kidney disease
Jiaan Huang, Fan Yang, Yan Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116185-116185
Open Access | Times Cited: 10
Jiaan Huang, Fan Yang, Yan Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116185-116185
Open Access | Times Cited: 10
Sirt6 overexpression relieves ferroptosis and delays the progression of diabetic nephropathy via Nrf2/GPX4 pathway
Lingyu Du, Canghui Guo, Shengnan Zeng, et al.
Renal Failure (2024) Vol. 46, Iss. 2
Open Access | Times Cited: 10
Lingyu Du, Canghui Guo, Shengnan Zeng, et al.
Renal Failure (2024) Vol. 46, Iss. 2
Open Access | Times Cited: 10
The role and mechanism of m6A methylation in diabetic nephropathy
Lin-Jing Yan, Liang Guo
Life Sciences (2025) Vol. 363, pp. 123355-123355
Closed Access | Times Cited: 1
Lin-Jing Yan, Liang Guo
Life Sciences (2025) Vol. 363, pp. 123355-123355
Closed Access | Times Cited: 1
Astragalus polysaccharide attenuates diabetic nephropathy by reducing apoptosis and enhancing autophagy through activation of Sirt1/FoxO1 pathway
Yanmei Xu, Xu Chen, Jie Huang, et al.
International Urology and Nephrology (2024) Vol. 56, Iss. 9, pp. 3067-3078
Closed Access | Times Cited: 6
Yanmei Xu, Xu Chen, Jie Huang, et al.
International Urology and Nephrology (2024) Vol. 56, Iss. 9, pp. 3067-3078
Closed Access | Times Cited: 6
Chinese herbal medicine and its active compounds in attenuating renal injury via regulating autophagy in diabetic kidney disease
Peng Liu, Wenhui Zhu, Yang Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Peng Liu, Wenhui Zhu, Yang Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Tight junction disruption and the pathogenesis of the chronic complications of diabetes mellitus: A narrative review
Ludivina Robles‐Osorio, Ernesto Sabath
World Journal of Diabetes (2023) Vol. 14, Iss. 7, pp. 1013-1026
Open Access | Times Cited: 12
Ludivina Robles‐Osorio, Ernesto Sabath
World Journal of Diabetes (2023) Vol. 14, Iss. 7, pp. 1013-1026
Open Access | Times Cited: 12
Brown adipose tissue alleviates podocyte apoptosis through NRG4 in a male mouse model of diabetic kidney disease
Sheng Ding, Jinling Xu, Jie Tong, et al.
Diabetologia (2025)
Closed Access
Sheng Ding, Jinling Xu, Jie Tong, et al.
Diabetologia (2025)
Closed Access
Canagliflozin Attenuates Podocyte Inflammatory Injury through Suppressing the TXNIP/NLRP3 Signaling Pathway in Diabetic Kidney Disease Mice
Siyu Li, Jiawen Wang, Ying Chen, et al.
Inflammation (2025)
Open Access
Siyu Li, Jiawen Wang, Ying Chen, et al.
Inflammation (2025)
Open Access
Renal intrinsic cells remodeling in diabetic kidney disease and the regulatory effects of SGLT2 Inhibitors
Wenwen Guo, Han Li, Yixuan Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115025-115025
Open Access | Times Cited: 10
Wenwen Guo, Han Li, Yixuan Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115025-115025
Open Access | Times Cited: 10
Research progress of natural active compounds on improving podocyte function to reduce proteinuria in diabetic kidney disease
Le Gong, Rui Wang, Xinyu Wang, et al.
Renal Failure (2023) Vol. 45, Iss. 2
Open Access | Times Cited: 10
Le Gong, Rui Wang, Xinyu Wang, et al.
Renal Failure (2023) Vol. 45, Iss. 2
Open Access | Times Cited: 10
A new perspective on proteinuria and drug therapy for diabetic kidney disease
Ruimin Zhang, Qian Wang, Yaqing Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Ruimin Zhang, Qian Wang, Yaqing Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients
Xiutian Chen, Jiali Wang, Yongda Lin, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 5
Xiutian Chen, Jiali Wang, Yongda Lin, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 5
CTRP4 attenuates apoptosis and epithelial-mesenchymal transition markers in podocytes through an AMPK/autophagy-dependent pathway
Wonjun Cho, Heeseung Oh, Sung Woo Choi, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 682, pp. 104-110
Closed Access | Times Cited: 4
Wonjun Cho, Heeseung Oh, Sung Woo Choi, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 682, pp. 104-110
Closed Access | Times Cited: 4
Supplemented Gegen Qinlian Decoction Formula attenuates podocyte mitochondrial fission and renal fibrosis in diabetic kidney disease by inhibiting TNF-α-mediated necroptosis, compared with empagliflozin
Yu Tian Wang, Lu Yu, Yajing Li, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118572-118572
Closed Access | Times Cited: 1
Yu Tian Wang, Lu Yu, Yajing Li, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118572-118572
Closed Access | Times Cited: 1
Low‑dose ionizing radiation attenuates high glucose‑induced hepatic apoptosis and immune factor release via modulation of a miR‑155‑SOCS1 axis
Hongqiong Fan, Shanshan Liu, Benzheng Jiao, et al.
Molecular Medicine Reports (2023) Vol. 28, Iss. 3
Open Access | Times Cited: 3
Hongqiong Fan, Shanshan Liu, Benzheng Jiao, et al.
Molecular Medicine Reports (2023) Vol. 28, Iss. 3
Open Access | Times Cited: 3
Understanding Proteinuria in Patients with Diabetic Kidney Disease and Progress of Drug Therapy from a New Perspective
Ruimin Zhang, Qian Wang, Xuefeng Zhou, et al.
(2023)
Open Access | Times Cited: 2
Ruimin Zhang, Qian Wang, Xuefeng Zhou, et al.
(2023)
Open Access | Times Cited: 2
DOT1L protects against podocyte injury in diabetic kidney disease through phospholipase C-like 1
Yepeng Hu, Shu Ye, Jing Kong, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Yepeng Hu, Shu Ye, Jing Kong, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
